| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae84ee010a36f11ad1c7ec51098aca0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-06 |
| filingDate |
1993-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f16145e9e307a3fb15fd7fa4fff6779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d223b99040f280139bc9e91f70932ce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f943d857a767dad3987550578208e2dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebd3d2416c511ed22be9cba5668fb2af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f71d0b29688ef0eb7eeac9a9ea12ea |
| publicationDate |
1995-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2036198-C1 |
| titleOfInvention |
N-METHYL- N- (α-D- GLUCOPYRANOSYL) -AMMONIUM -2-(ACRIDONE -9-ONE -10-YL) -ACETATE (CYCLOFERON) SHOWING INTERFEROGENIC, ANTIVIRAL AMONG THEM ANTI-HIV, ANTIPARASITIC, ANTIPROMOTER AND RADIOPROTECTIVE ACTIVITIES |
| abstract |
FIELD: organic chemistry. SUBSTANCE: product: N-methyl-N- (a-D-glucopyranosyl)-ammonium-2-(acridone-9-one-- 10-yl)-acetate, empirical formula is C 22 H 26 N 2 O 8 ,, m. p. is 129-132 C, yield is 100%. Reagent 1: N-methyl-N-(α-D-glucopyranosylamine). Reagent 2: 2-(acridone-9-one-10-yl)-acetic acid. Reaction conditions: in ethanol medium, at the room temperature. Product structure is given in description. Synthesized compound is used in medicine. EFFECT: improved method of synthesis. 11 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2449792-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007058568-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9813352-A1 |
| priorityDate |
1993-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |